Safety of Effivia®, a Bevacizumab Biosimilar

Clinical trial NCT06313268 · COMPLETED

Trial details

NCT number: NCT06313268
Sponsor: Laboratorios Liomont
Status: COMPLETED
Study type: OBSERVATIONAL

Metastatic Colorectal Cancer Metastatic Cervical Cancer Non Squamous Non Small Cell Lung Cancer

Start date: 2022-08-11
Primary completion: 2024-04-17
Enrollment: 83

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.